Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 47 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION Filling date: 27 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING PMP22 EXPRESSION Filling date: 27 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ANGIOTENSIN II TYPE 1 RECEPTOR TARGETED OLIGONUCLEOTIDES AND USES THEREOF Filling date: 27 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: Compositions for Modulating Ataxin 2 Expression Filling date: 27 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING KCNT1 EXPRESSION Filling date: 27 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Modulators of diacyglycerol acyltransferase 2 (DGAT2) Filling date: 27 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: MODULATION OF GYS1 EXPRESSION Filling date: 27 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Compounds and methods for modulating SMN2 Filling date: 27 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: Compounds and Methods for Use in Dystrophin Transcript Filling date: 27 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF SMN2 Filling date: 27 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION Filling date: 27 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: 5' modified nucleosides and oligomeric compounds prepared therefrom Filling date: 27 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION Filling date: 27 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: Compounds and methods for modulating UBE3A-ATS Filling date: 27 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Compounds and methods for modulating C90RF72 Filling date: 27 Sep 2025 Issue date: 1 Mar 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING PLP1 Filling date: 27 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN Filling date: 27 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Modulators of IRF4 expression Filling date: 27 Sep 2025 Issue date: 8 Feb 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATION OF LMNA EXPRESSION Filling date: 27 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Modulation of GYS1 expression Filling date: 27 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 27 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE Filling date: 27 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING PRION EXPRESSION Filling date: 27 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION Filling date: 27 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Modulators of YAP1 expression Filling date: 27 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION Filling date: 27 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Modulation of the notch signaling pathway for treatment of respiratory disorders Filling date: 27 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Combinations for the modulation of SMN expression Filling date: 27 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Morpholino modified oligomeric compounds Filling date: 27 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Compositions and methods for modulating Tau expression Filling date: 27 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: MODULATION OF LNC05 EXPRESSION Filling date: 27 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: METHODS FOR TREATING HYPERCHOLESTEROLEMIA Filling date: 27 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHOD OF CONJUGATING OLIGOMERIC COMPOUNDS Filling date: 27 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Modulation of angiopoietin-like 3 expression Filling date: 27 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 27 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING UBE3A-ATS Filling date: 27 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: Compositions and Methods for Modulating PKK Expression Filling date: 27 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHODS FOR SAFELY REDUCING THROMBOPOIETIN Filling date: 27 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: Compositions for modulating Ataxin 2 expression Filling date: 27 Sep 2025 Issue date: 7 Sep 2021 |
Application | Utility: Modified Compounds and Uses Thereof Filling date: 27 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: LINKAGE MODIFIED OLIGOMERIC COMPOUNDS Filling date: 27 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR INCREASING STMN2 EXPRESSION Filling date: 27 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom Filling date: 27 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Compounds and methods for reducing ATXN2 expression Filling date: 27 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Compositions comprising alternating 2'-modified nucleosides for use in gene modulation Filling date: 27 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: Compositions for Modulating C9ORF72 Expression Filling date: 27 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Compositions and their uses directed to huntingtin Filling date: 27 Sep 2025 Issue date: 27 Jul 2021 |
Showing 1 to 47 of 47 patents.